The FDA, Unicure, and the Limits of Accelerated Approval

The FDA, Unicure, and the Limits of Accelerated Approval

Author: The Doctor's Lounge May 25, 2026 Duration: 53:09

Episode Summary

Anish sits down with Adu, a med student and biotech investor, to work through the FDA's contested handling of Unicure's AMT-130 — a gene therapy for Huntington's disease delivered via stereotactic brain injection. They debate whether the underlying data justifies approval, why the agency's mid-course reversal has rattled the investor community, and what the Sarepta precedent should have taught everyone involved. The conversation broadens into a bigger question: given that desperate patient populations will always demand access to anything showing a signal, who is actually best positioned to make the call on whether a drug works — the FDA, the clinician, or the market?

Chapter Markers

00:00 FDA approval of AMT-130 and investor reaction

01:16 Unmet need and the case for regulatory flexibility

02:37 Sarepta, Duchenne's, and the cost of approving under pressure

05:09 Accelerated approval done right: the Amylyx example

09:14 Debating the AMT-130 data and the historical control problem

13:53 Why stock price matters for trial funding

17:20 How Prasad could have changed FDA culture differently

19:37 The FDA's role from Kefauver-Harris to today

22:26 Competing Huntington's therapies in the pipeline

25:39 Prasad's tenure: what worked, what didn't

28:27 Media coverage of the FDA and science journalism

Co-Host Handles

@anish_koka and @drdigiorgio

Show Handle

@drsloungepod


In The Doctor's Lounge, the white coat comes off for a conversation that moves freely from the exam room to the boardroom. This isn't a lecture hall; it's the back table where practicing physicians gather to unpack the complex systems that define modern medicine. Hosted by Dutch Rojas and Anthony DiGiorgio, DO, with regular voices like Anish Koka, MD, Dan Choi, MD, and Sanat Dixit, MD, the discussions are built on frontline experience. You'll hear unfiltered perspectives on the policy debates that shape care, the realities of navigating business and entrepreneurship within a medical practice, and the constant push for meaningful reform. The dialogue is grounded in a shared commitment to physician autonomy and, ultimately, better patient outcomes. Each episode in this podcast connects the dots between clinical fitness and the health of the medical profession itself, offering a rare look at the challenges and opportunities that exist where patient care meets the mechanics of the healthcare industry. It's a space for the nuanced, often contentious, and always real conversations happening behind the scenes.
Author: Language: English Episodes: 61

The Doctor's Lounge
Podcast Episodes
The ER Doc Who Quit the System  - and Built His Own [not-audio_url] [/not-audio_url]

Duration: 1:02:16
Episode SummaryDr. Noah Kaufman - board-certified emergency physician with 20 years in the ER, seven seasons on American Ninja Warrior, and a new direct acute care practice in Denver - joins Drs. Koka and DiGiorgio to ta…
Free Markets, Private Equity, and the Moral Case for Medicine [not-audio_url] [/not-audio_url]

Duration: 1:26:47
Episode SummaryJared Rhoads, founder of the Center for Modern Health and senior lecturer in health policy at the Dartmouth Institute, joins Drs. Koka and DiGiorgio for a wide-ranging conversation on the philosophical fou…
From Babylon to Baylor: How Insurance Went Off the Rails [not-audio_url] [/not-audio_url]

Duration: 34:01
Anish and Dr. DiGiorgio trace the history of insurance from ancient Babylonian bottomery contracts through Egyptian workers' guilds, Greek risk-pooling societies, Lloyd's of London, and the birth of actuarial science — t…